These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 15863303)
41. Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents. Liang G; Shao L; Wang Y; Zhao C; Chu Y; Xiao J; Zhao Y; Li X; Yang S Bioorg Med Chem; 2009 Mar; 17(6):2623-31. PubMed ID: 19243951 [TBL] [Abstract][Full Text] [Related]
42. Novel polymeric prodrug with multivalent components for cancer therapy. Khandare JJ; Chandna P; Wang Y; Pozharov VP; Minko T J Pharmacol Exp Ther; 2006 Jun; 317(3):929-37. PubMed ID: 16469865 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy. Masterson LA; Spanswick VJ; Hartley JA; Begent RH; Howard PW; Thurston DE Bioorg Med Chem Lett; 2006 Jan; 16(2):252-6. PubMed ID: 16290933 [TBL] [Abstract][Full Text] [Related]
44. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes. Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877 [TBL] [Abstract][Full Text] [Related]
45. Design, synthesis, and antitumor activity of bile acid-polyamine-nucleoside conjugates. Wu D; Ji S; Wu Y; Ju Y; Zhao Y Bioorg Med Chem Lett; 2007 Jun; 17(11):2983-6. PubMed ID: 17416522 [TBL] [Abstract][Full Text] [Related]
46. Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation. Yin H; Xu Y; Qian X; Li Y; Liu J Bioorg Med Chem Lett; 2007 Apr; 17(8):2166-70. PubMed ID: 17331719 [TBL] [Abstract][Full Text] [Related]
47. Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines. Onnis V; Cocco MT; Fadda R; Congiu C Bioorg Med Chem; 2009 Sep; 17(17):6158-65. PubMed ID: 19679483 [TBL] [Abstract][Full Text] [Related]
48. Asymmetric synthesis and biological evaluation of glycosidic prodrugs for a selective cancer therapy. Tietze LF; von Hof JM; Krewer B; Müller M; Major F; Schuster HJ; Schuberth I; Alves F ChemMedChem; 2008 Dec; 3(12):1946-55. PubMed ID: 19021160 [TBL] [Abstract][Full Text] [Related]
49. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343 [TBL] [Abstract][Full Text] [Related]
50. Design, synthesis, and antitumor activity of new bis-aminomethylnaphthalenes. Bollini M; Casal JJ; Bruno AM Bioorg Med Chem; 2008 Sep; 16(17):8003-10. PubMed ID: 18715786 [TBL] [Abstract][Full Text] [Related]
51. Design and Synthesis of Polymer Prodrugs for Improving Water-Solubility, Pharmacokinetic Behavior and Antitumor Efficacy of TXA9. Li Y; Ye C; Cai C; Zhao M; Han N; Liu Z; Zhai J; Yin J Pharm Res; 2020 Mar; 37(3):66. PubMed ID: 32166420 [TBL] [Abstract][Full Text] [Related]
52. Antibody-directed enzyme prodrug therapy: a promising approach for a selective treatment of cancer based on prodrugs and monoclonal antibodies. Tietze LF; Krewer B Chem Biol Drug Des; 2009 Sep; 74(3):205-11. PubMed ID: 19660031 [TBL] [Abstract][Full Text] [Related]
53. Gluconjugates of 8-hydroxyquinolines as potential anti-cancer prodrugs. Oliveri V; Giuffrida ML; Vecchio G; Aiello C; Viale M Dalton Trans; 2012 Apr; 41(15):4530-5. PubMed ID: 22354329 [TBL] [Abstract][Full Text] [Related]
54. Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate. Marathe PH; Kamath AV; Zhang Y; D'Arienzo C; Bhide R; Fargnoli J Cancer Chemother Pharmacol; 2009 Dec; 65(1):55-66. PubMed ID: 19396600 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and biological evaluation of new 4beta-anilino- and 4beta-imido-substituted podophyllotoxin congeners. Kamal A; Gayatri NL; Reddy DR; Mohan Reddy PS; Arifuddin M; Dastidar SG; Kondapi AK; Rajkumar M Bioorg Med Chem; 2005 Nov; 13(22):6218-25. PubMed ID: 16061385 [TBL] [Abstract][Full Text] [Related]
57. Discovery of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers. 2. Identification of more aqueous soluble analogs as potential anticancer agents. Kemnitzer W; Kuemmerle J; Zhang HZ; Kasibhatla S; Tseng B; Drewe J; Cai SX Bioorg Med Chem Lett; 2009 Aug; 19(15):4410-5. PubMed ID: 19500976 [TBL] [Abstract][Full Text] [Related]
58. Lessons learned from marketed and investigational prodrugs. Ettmayer P; Amidon GL; Clement B; Testa B J Med Chem; 2004 May; 47(10):2393-404. PubMed ID: 15115379 [No Abstract] [Full Text] [Related]
59. Design, synthesis, and biological evaluation of pyrrolo[2,1-c][1,4]benzodiazepine and indole conjugates as anticancer agents. Wang JJ; Shen YK; Hu WP; Hsieh MC; Lin FL; Hsu MK; Hsu MH J Med Chem; 2006 Feb; 49(4):1442-9. PubMed ID: 16480280 [TBL] [Abstract][Full Text] [Related]
60. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance. Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]